Vimarsana
Biggest News Aggregation in the World

Page 3 - Beyondspring Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Beyondspring Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Beyondspring Inc Today - Breaking & Trending Today

SEED Therapeutics Discloses Novel Molecular Glue IND Candidate for Cancer at "Targeted Protein Degradation Think Tank" Symposium - Vimarsana News

SEED Therapeutics Discloses Novel Molecular Glue IND Candidate for Cancer at "Targeted Protein Degradation Think Tank" Symposium

NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- SEED Therapeutics Inc. (“SEED”), a biotech company focused on harnessing and engineering Molecular G...

2023-10-23 | NDAQ:BYSI | Press Release | Beyondspring Inc - Vimarsana News

2023-10-23 | NDAQ:BYSI | Press Release | Beyondspring Inc

(2023-10-23 | NDAQ:BYSI) SEED Therapeutics, a BeyondSpring Subsidiary, Appoints Mr. Ko-Yung Tung to the Board of Directors

Why Comtech Telecommunications Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket - Blue Star Foods (NASDAQ:BSFC), Bio-Path Hldgs (NASDAQ:BPTH) - Vimarsana News

Why Comtech Telecommunications Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket - Blue Star Foods (NASDAQ:BSFC), Bio-Path Hldgs (NASDAQ:BPTH)

Gainers Oblong, Inc. (NASDAQ: OBLG) shares rose 295.7% to $1.16 in pre-market trading.

BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid - Vimarsana News

BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid

NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical...

BeyondSpring : Form 20-F T Form 40-F □ - Form 6-K -September 20, 2023 at 05:23 pm EDT - Vimarsana News

BeyondSpring : Form 20-F T Form 40-F □ - Form 6-K -September 20, 2023 at 05:23 pm EDT

Form 20-F T Form 40-F □ As previously reported on a Form 6-K filed by BeyondSpring Inc. , Dalian Wanchunbulin Pharmaceuticals Ltd. , the Company's 58%-owned...